Board MeetingOutcome of Board Meeting

Ipca Labs announced the financial results for the quarter: consolidated net profit surged 80% to ₹422.81 Cr, with total income up 20% to ₹2813.36 Cr.

IPCA Laboratories Limited logo
IPCA Laboratories LimitedIPCALAB · Filed with the exchange

The board also approved the amalgamation of Krebs Biochemicals & Industries Ltd., effective April 1, 2026, pending approvals.

Read the original filing(PDF)

No comments yet. Be the first.

More from IPCA Laboratories Limited

All announcements